Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It markets its tests through internal sales force, as well as through independent sales representatives in the United States, Canada, the People's Republic of China, and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:FLGT
CUSIPN/A
Phone626-350-0537
Debt
Debt-to-Equity RatioN/A
Current Ratio15.03
Quick Ratio15.03
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$18.73 million
Price / Sales4.78
Cash Flow$0.0035 per share
Price / Cash1,414.51
Book Value$3.04 per share
Price / Book1.64
Profitability
EPS (Most Recent Fiscal Year)($0.11)
Net Income$-2,510,000.00
Net Margins-26.57%
Return on Equity-7.62%
Return on Assets-7.22%
Miscellaneous
Employees98
Outstanding Shares17,890,000
Market Cap$89.44
Fulgent Genetics (NASDAQ:FLGT) Frequently Asked Questions
What is Fulgent Genetics' stock symbol?
Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."
How were Fulgent Genetics' earnings last quarter?
Fulgent Genetics Inc (NASDAQ:FLGT) announced its earnings results on Monday, May, 7th. The company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by $0.02. The business earned $4.65 million during the quarter. Fulgent Genetics had a negative return on equity of 7.62% and a negative net margin of 26.57%. View Fulgent Genetics' Earnings History.
When is Fulgent Genetics' next earnings date?
What price target have analysts set for FLGT?
2 brokerages have issued 1 year price objectives for Fulgent Genetics' shares. Their predictions range from $5.00 to $7.00. On average, they anticipate Fulgent Genetics' stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 20.0% from the stock's current price. View Analyst Ratings for Fulgent Genetics.
What is the consensus analysts' recommendation for Fulgent Genetics?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
Who are some of Fulgent Genetics' key competitors?
Who are Fulgent Genetics' key executives?
Fulgent Genetics' management team includes the folowing people:
- Mr. Ming Hsieh, Chairman, CEO & Pres (Age 62)
- Mr. Paul Kim, Chief Financial Officer (Age 51)
- Dr. Han Lin Gao, Chief Scientific Officer & Lab Director (Age 51)
- Joe Roach, VP
When did Fulgent Genetics IPO?
(FLGT) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,600,000 shares at $12.00-$14.00 per share. Credit Suisse and Piper Jaffray served as the underwriters for the IPO and Raymond James and BTIG were co-managers.
Has Fulgent Genetics been receiving favorable news coverage?
Media headlines about FLGT stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Fulgent Genetics earned a media sentiment score of 0.18 on Accern's scale. They also assigned media coverage about the company an impact score of 45.53 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of Fulgent Genetics?
Shares of FLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Fulgent Genetics' stock price today?
One share of FLGT stock can currently be purchased for approximately $5.00.
How big of a company is Fulgent Genetics?
Fulgent Genetics has a market capitalization of $89.44 million and generates $18.73 million in revenue each year. The company earns $-2,510,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. Fulgent Genetics employs 98 workers across the globe.
How can I contact Fulgent Genetics?
Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]
MarketBeat Community Rating for Fulgent Genetics (NASDAQ FLGT)
MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Vote "Outperform" if you believe FLGT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.
